ROMAN A SHINGAREV

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology SOUTH SALT LAKE, UT NPI 1457564601

General Payments — all program years on this page

$1,626.83

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 53
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $835.98 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $835.9839

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $107.781
2022 $437.713
2023 $245.3610
2024 $835.9839

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082024093 CorMedix Inc. $13.58 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087322031 Novartis Pharmaceuticals Corporation $16.94 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087322039 Novartis Pharmaceuticals Corporation $14.53 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087322041 Novartis Pharmaceuticals Corporation $31.03 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087322043 Novartis Pharmaceuticals Corporation $14.50 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087322045 Novartis Pharmaceuticals Corporation $14.68 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093911095 Alexion Pharmaceuticals, Inc. $18.41 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094033420 Alexion Pharmaceuticals, Inc. $19.32 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104344524 AstraZeneca Pharmaceuticals LP $18.54 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104545614 AstraZeneca Pharmaceuticals LP $14.04 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104612350 AstraZeneca Pharmaceuticals LP $77.89 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105452733 AstraZeneca Pharmaceuticals LP $15.19 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105507768 AstraZeneca Pharmaceuticals LP $16.00 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105578018 AstraZeneca Pharmaceuticals LP $13.83 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105665698 AstraZeneca Pharmaceuticals LP $22.92 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116120380 Amgen Inc. $29.46 01/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116120386 Amgen Inc. $18.39 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117683076 Amgen Inc. $16.41 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117683078 Amgen Inc. $14.74 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839727 Otsuka Pharmaceutical Development & Commercialization, Inc. $25.32 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118981817 Otsuka America Pharmaceutical, Inc. $14.06 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118981819 Otsuka America Pharmaceutical, Inc. $18.23 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118981821 Otsuka America Pharmaceutical, Inc. $17.66 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118981823 Otsuka America Pharmaceutical, Inc. $17.11 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118981825 Otsuka America Pharmaceutical, Inc. $14.19 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124034509 Vifor Pharma, Inc. $15.61 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124037431 Vifor Pharma, Inc. $21.63 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124044085 Vifor Pharma, Inc. $25.61 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124044724 Vifor Pharma, Inc. $27.61 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124046063 Vifor Pharma, Inc. $26.63 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135338569 Lilly USA, LLC $29.82 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135374048 Lilly USA, LLC $31.29 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146707810 Ardelyx, Inc. $19.50 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146707812 Ardelyx, Inc. $16.78 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146707814 Ardelyx, Inc. $18.69 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146707816 Ardelyx, Inc. $32.52 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149887361 Travere Therapeutics, Inc. $29.53 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154207282 Fresenius USA Marketing, Inc. $18.06 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154282989 NXSTAGE MEDICAL, INC. $15.73 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.